2 Sources
[1]
Earnings call: ModivCare maintains guidance despite mixed Q2 results By Investing.com
ModivCare Inc. (MODV), a leading provider of healthcare services, reported its financial results for the second quarter of 2024. The company announced an adjusted EBITDA of $45 million and revenue of $698 million, which remained flat year-over-year. Despite growth in the non-emergency medical
[2]
Earnings call: D-Wave reports robust Q2 2024 growth, expands quantum AI By Investing.com
In a recent earnings call, D-Wave Systems Inc. (NYSE: QBTS) CEO Dr. Alan Baratz discussed the company's strong performance in the second quarter of 2024. D-Wave, known for its annealing quantum computing solutions, announced significant growth in various sectors, including an expanded partnership
Share
Copy Link
Modivcare faces challenges but maintains 2023 guidance, while D-Wave Systems reports strong Q2 2024 growth and expands its quantum AI offerings.

Modivcare Inc., a technology-enabled healthcare services company, reported mixed results for the second quarter of 2023. Despite facing challenges, the company has maintained its full-year 2023 guidance. The earnings call revealed that Modivcare's net service revenue increased to $475.7 million, up from $456.7 million in the same quarter last year
1
.However, the company reported a net loss of $15.5 million, or $1.09 per share, compared to a net income of $1.1 million, or $0.08 per share, in Q2 2022. Adjusted EBITDA also decreased to $37.1 million from $45.3 million year-over-year. Despite these challenges, Modivcare's management expressed confidence in their ability to meet full-year expectations.
In contrast, D-Wave Systems Inc., a quantum computing systems, software, and services company, reported robust growth for its fiscal second quarter of 2024. The company's revenue increased by 51% year-over-year to $1.7 million
2
.D-Wave's growth was driven by strong bookings, which more than doubled compared to the previous year. The company also reported a significant increase in its sales pipeline, growing by over 70% year-over-year to $81 million.
Modivcare's CEO, L. Heath Sampson, highlighted the company's focus on operational improvements and cost reduction initiatives. These efforts are expected to drive margin expansion in the second half of 2023. The company is also investing in technology and centralization to enhance efficiency and service quality.
D-Wave has been making significant strides in expanding its quantum AI offerings. The company launched its Quantum Generative AI service, which aims to accelerate the development of foundation models. This service has already garnered interest from major technology companies and is expected to contribute to D-Wave's future growth.
Related Stories
Modivcare's stock performance following the earnings report was not explicitly mentioned in the source. However, the company's maintained guidance suggests a cautiously optimistic outlook for the remainder of 2023.
D-Wave, on the other hand, saw its stock price increase by 5% following the earnings announcement. The company's strong growth and expanding quantum AI offerings have positioned it well in the rapidly evolving quantum computing market.
These earnings reports highlight the diverse landscape of the technology and healthcare sectors. While Modivcare faces short-term challenges in its healthcare services business, D-Wave's growth underscores the increasing interest and investment in quantum computing and AI technologies.
As both companies navigate their respective markets, investors and industry observers will be closely watching how Modivcare's cost-saving initiatives play out and how D-Wave's quantum AI offerings continue to develop and gain traction in the market.
Summarized by
Navi
[1]
1
Technology

2
Policy and Regulation

3
Technology
